TOP STORIES

• REGULATORY Shionogi’s COVID-19 Pill Up for Expert Redeliberation on July 20
  July 14, 2022

• BUSINESS Shionogi’s Four-Day Workweek Not So Popular Yet, but Side Job Plan Gaining Traction
  July 13, 2022

• ORGANIZATION JPMA Think Tank Finds Surge in Japan-Unapproved Drugs in Areas with High Unmet Needs
  July 12, 2022

• REGULATORY After Abe’s Death, Pharma and Medical Circles Fret Shift to Austerity and Tougher Drug Pricing
  July 11, 2022

• BUSINESS As LOEs Loom, Can Mochida Roll Out Authorized Generics for Lexapro and Lialda?
  July 8, 2022

• REGULATORY All Eyes on Scope of Drugs Possibly Designated as Key Resources; Full Discussions after Upper House Poll
  July 7, 2022

• BUSINESS Lecanemab Accepted for US Review, Action Date Set for January: Eisai/Biogen
  July 7, 2022

• BUSINESS Astellas Looks to Beat Innovation Malaise through Organizational and HR Rejig
  July 6, 2022

• REGULATORY MHLW Preparing Inspection Manual after GMP Issues, Draft Due Out by March-End
  July 5, 2022

• BUSINESS Shionogi Starts Document Submission for COVID Pill in China
  July 5, 2022

• BUSINESS BMS Japan Launches New Head Office as It Looks to Spur Ideas through Casual Chats
  July 5, 2022

• BUSINESS Chugai Best-Paying Japan Pharma in FY2021, 25 Drug Makers Pay Average 8.33 Million Yen
  July 4, 2022

• BUSINESS 37 Pharma Execs Get 100 Million-Plus Yen in FY2021, Top 3 at Takeda: Securities Reports
  July 1, 2022

• REGULATORY Japan Begins TPOXX Clinical Research as It Braces for Monkeypox Outbreak
  June 30, 2022

• BUSINESS Wholesalers Bear Over 50 Billion Yen in Annual Costs Tied to Restricted Drug Supply: Crecon Estimate
  June 29, 2022

• BUSINESS Astellas/Sutro to Codevelop Next-Gen Immunostimulatory ADCs for Cold Tumors
  June 29, 2022

• BUSINESS Bimzelx as Driver, UCB Set to Derive Half of Global Sales from Immunology Biz
  June 28, 2022

• COMMENTARY Japan Should Accelerate Debate on Legalizing Cannabis-Derived Drugs for Refractory Epilepsies
  June 27, 2022

• ORGANIZATION Kichiro Matsumoto Elected as New Chief of Japan Medical Association
  June 27, 2022

• BUSINESS 25 Japan Drug Makers Log Combined 10.7% Growth in FY2021, 12 See Two-Digit Jumps: Tally
  June 24, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 69
• 70
• 71
• 72
• 73
• 74
• 75
• 76
• 77
• …
• Next ›
• 最終 »